Viral dynamics and CD4+ T cell counts in subtype C human immunodeficiency virus type 1-infected individuals from southern Africa.

No abstract is available for this paper.

• Publication year

  2005

• Venue

  AIDS Research and Human Retroviruses

• Publication date

  2005-04-25

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1089/AID.2005.21.285PMID 15943570
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Dynamic HIV/AIDS parameter estimation with application to a vaccine readiness study in Southern Africa

  2005cited by this paper
• Incidence of HIV-1 dual infection and its association with increased viral load set point in a cohort of HIV-1 subtype C-infected female sex workers.

  2004cited by this paper
• AIDS in Africa: the impact of coinfections on the pathogenesis of HIV-1 infection.

  2004cited by this paper
• Comparison of Human Immunodeficiency Virus Type 1 Viral Loads in Kenyan Women, Men, and Infants during Primary and Early Infection

  2003cited by this paper
• Lymphocyte subset enumeration in HIV seronegative and HIV-1 seropositive adults in Dar es Salaam, Tanzania: determination of reference values in males and females and comparison of two flow cytometric methods.

  2003cited by this paper
• No difference in clinical progression between patients infected with the predominant human immunodeficiency virus type 1 circulating recombinant form (CRF) 02_AG strain and patients not infected with CRF02_AG, in Western and West-Central Africa: a four-year prospective multicenter study.

  2002cited by this paper
• Higher viral loads and other risk factors associated with HIV-1 seroconversion during a period of high incidence among injection drug users in Bangkok.

  2002cited by this paper
• Clinical and Biological Evolution of HIV‐1 Seroconverters in Abidjan, Côte d’Ivoire, 1997‐2000

  2002cited by this paper
• Effect of human immunodeficiency virus (HIV) type 1 envelope subtypes A and D on disease progression in a large cohort of HIV-1-positive persons in Uganda.

  2002cited by this paper
• Gender Difference in HIV RNA Levels: A Meta‐Analysis of Published Studies

  2002cited by this paper
• Primary HIV‐1 Subtype C Infection in Ethiopia

  2002cited by this paper
• The Development of HIV‐1 Subtype C Vaccines for Southern Africa

  2002cited by this paper
• Rapid Disease Progression in Human Immunodeficiency Virus Type 1-Infected Seroconverters in India

  2002cited by this paper
• Underevaluation of HIV-1 plasma viral load by a commercially available assay in a cluster of patients infected with HIV-1 A/G circulating recombinant form (CRF02).

  2002cited by this paper
• Human immunodeficiency virus Type 1 (HIV-1) plasma virus load and markers of immune activation among HIV-infected female sex workers with sexually transmitted diseases in Abidjan, Côte d'Ivoire.

  2001cited by this paper
• Early human immunodeficiency virus (HIV) infection in the HIV Network for Prevention Trials Vaccine Preparedness Cohort: risk behaviors, symptoms, and early plasma and genital tract virus load.

  2001cited by this paper
• Initial plasma HIV-1 RNA levels and progression to AIDS in women and men.

  2001cited by this paper
• Small variations in multiple parameters account for wide variations in HIV–1 set–points: a novel modelling approach

  2001cited by this paper
• Course of viral load throughout HIV-1 infection.

  2000cited by this paper
• Performance of Five Different Assays for the Quantification of Viral Load in Persons Infected With Various Subtypes of HIV‐1

  2000cited by this paper
• Course of Viral Load Throughout HIV‐1 Infection

  2000cited by this paper
• Fluctuations in HIV‐1 Viral Load Are Correlated to CD4+ T‐Lymphocyte Count During the Natural Course of Infection

  2000cited by this paper
• Association of HIV-1 load and CD4 lymphocyte count with mortality among untreated African children over one year of age

  2000cited by this paper
• Plasma viral load in HIV-1 and HIV-2 singly and dually infected individuals in Guinea-Bissau, West Africa: significantly lower plasma virus set point in HIV-2 infection than in HIV-1 infection.

  2000cited by this paper
• Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study.

  2000cited by this paper
• Performance of five different assays for the quantification of viral load in persons infected with various subtypes of HIV-1. Swiss HIV Cohort Study.

  2000cited by this paper
• Fluctuations in HIV-1 viral load are correlated to CD4+ T-lymphocyte count during the natural course of infection.

  2000cited by this paper
• Sex differences in longitudinal human immunodeficiency virus type 1 RNA levels among seroconverters.

  1999cited by this paper
• Similar rate of disease progression among individuals infected with HIV-1 genetic subtypes A-D.

  1999cited by this paper
• Human immunodeficiency virus type 1 subtypes differ in disease progression.

  1999cited by this paper
• Lack of evidence of a stable viral load set‐point in early stage asymptomatic patients with chronic HIV‐1 infection

  1998cited by this paper
• Biological and Virologic Characteristics of Primary HIV Infection

  1998cited by this paper
• Convergence Properties of the Nelder-Mead Simplex Method in Low Dimensions

  1998cited by this paper
• AIDS prognosis based on HIV‐1 RNA, CD4+ T‐cell count and function: markers with reciprocal predictive value over time after seroconversion

  1997cited by this paper
• Population Dynamics of Immune Responses to Persistent Viruses

  1996cited by this paper
• Prognosis in HIV-1 Infection Predicted by the Quantity of Virus in Plasma

  1996cited by this paper
• Viral dynamics in vivo: limitations on estimates of intracellular delay and virus decay.

  1996cited by this paper
• Natural history of HIV-1 cell-free viremia.

  1995cited by this paper
• Circulating HIV-1-infected cell burden from seroconversion to AIDS: importance of postseroconversion viral load on disease course.

  1994cited by this paper

• Virological remission after antiretroviral therapy interruption in female African HIV seroconverters

  2019cites this paper
• Implementation and Operational Research: Evolution of Couples' Voluntary Counseling and Testing for HIV in Rwanda: From Research to Public Health Practice

  2016cites this paper
• Functional and clinical consequences of immune-driven sequence variation of gag-protease in HIV-1 subtypes A, C, D and recombinants.

  2016cites this paper
• Pretreatment HIV Drug Resistance and HIV-1 Subtype C Are Independently Associated With Virologic Failure: Results From the Multinational PEARLS (ACTG A5175) Clinical Trial.

  2015cites this paper
• Disease progression by in fecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa

  2013cites this paper
• Disease progression by infecting HIV-1 subtype in a seroconverter cohort in sub-Saharan Africa

  2013cites this paper
• High Rate of Non-detectable HIV-1 RNA Among Antiretroviral Drug Naive HIV Positive Individuals in Nigeria

  2013cites this paper
• VALIDATION AND LONGITUDINAL APPLICATION OF THE WHOQOL-HIV QUESTIONNAIRE AMONG PEOPLE LIVING WITH HIV AND AIDS IN LIMPOPO PROVINCE, SOUTH AFRICA

  2012cites this paper
• Characterization of acute HIV-1 infection in high-risk Nigerian populations.

  2012cites this paper
• Evolution of HIV-1 subtype C immune responses during acute and chronic HIV infection

  2011cites this paper
• Intérêt d'une cohorte de sujets adultes à date d'infection par le VIH estimée en Afrique Sub-saharienne

  2011cites this paper
• HIV-1 Subtype C-Infected Individuals Maintaining High Viral Load as Potential Targets for the “Test-and-Treat” Approach to Reduce HIV Transmission

  2010cites this paper
• Viral tropism, fitness and pathogenicity of HIV-1 subtype C

  2010cites this paper
• ESTIMATION OF CONSTANT AND TIME-VARYING DYNAMIC PARAMETERS OF HIV INFECTION IN A NONLINEAR DIFFERENTIAL EQUATION MODEL.

  2010cites this paper
• Use of predictive markers of HIV disease progression in vaccine trials.

  2009cites this paper
• Clinical Prognostic Value of RNA Viral Load and CD4 Cell Counts during Untreated HIV-1 Infection—A Quantitative Review

  2009cites this paper
• Viral Load and CD4+ T-Cell Dynamics in Primary HIV-1 Subtype C Infection

  2009cites this paper
• CCR5- and CXCR4-Tropic Subtype C Human Immunodeficiency Virus Type 1 Isolates Have a Lower Level of Pathogenic Fitness than Other Dominant Group M Subtypes: Implications for the Epidemic

  2009cites this paper
• HIV‐1 seroconversion promotes rapid changes in cervical human papillomavirus (HPV) prevalence and HPV‐16 antibodies in female sex workers

  2009cites this paper
• HIV-1 Genetic Diversity and Its Biological Significance

  2009cites this paper
• The challenge of HIV-1 subtype diversity.

  2008cites this paper
• Identifiability Problems of Time-delay HIV Models

  2008cites this paper
• Incidence of HIV infection in rural KwaZulu-Natal in the context of the epidemiology and impact of HIV/AIDS in South Africa.

  2007cites this paper
• Modelling of HIV infection: Vaccine readiness, drug effectiveness and therapeutical failures

  2007influential citation
• Genetic characteristics of HIV-1 subtype C envelopes inducing cross-neutralizing antibodies.

  2007cites this paper
• Is HIV-1 evolving to a less virulent form in humans?

  2007cites this paper
• Clinical impact of HIV-1 subtype: are there important differences?

  2007cites this paper
• Measurement of antigen specific immune responses: 2006 update

  2007cites this paper
• HIV-1 Subtype C Infection: Response to Treatment as a Function of Disease Progression

  2006cites this paper
• A Control Theoretic Approach to HIV/AIDS Drug Dosage Design and Timing the Initiation of Therapy

  2006cites this paper
• The T Cell in HIV infection and disease Primary HIV infection: impact of early treatment and modulation of the HIV- specific cellular immune response

  2005cites this paper
• Dynamic HIV/AIDS parameter estimation with application to a vaccine readiness study in Southern Africa

  2005cites this paper
• Directorate Professor Bd Schoub Mb Bch Mmed Md Dsc Frcpath Fcpath (sa) Frssaf Executive Director I Latsky, Personal Assistant D Van Der Sandt Bcomm (hons) Mbc, Corporate Services Manager Microbiology Microbiology Microbiology Microbiology Microbiology Parasitology Reference Unit Current Research Pro

  year unknowncites this paper